Modern Research Trends in Dentistry: A Cross-Disciplinary Perspective Based on Pharmaceutical Innovations

Dentistry, traditionally focused on mechanical interventions, is undergoing a paradigm shift with the incorporation of pharmaceutical sciences. This interdisciplinary approach addresses complex oral health challenges, offering novel solutions for drug delivery, disease management and patient care. The ensuing sections delve into specific pharmaceutical innovations and their transformative impact on modern dentistry.

Sustained and sublingual drug delivery in oral health

Effective management of chronic oral conditions necessitates consistent therapeutic levels of medication. Sustained-release formulations, particularly matrix tablets, have demonstrated efficacy in maintaining drug concentrations over extended periods, reducing dosing frequency and enhancing patient compliance [1]. Such formulations are particularly beneficial in managing periodontal diseases, where prolonged drug exposure is critical. Sublingual drug delivery offers rapid systemic absorption, bypassing the hepatic first-pass effect. The formulation and evaluation of sublingual tablets of lisinopril exemplify this approach, providing swift therapeutic action, which can be crucial during dental procedures that may induce hypertensive episodes [2].

Taste masking in pediatric dentistry

Palatability significantly influences medication adherence, especially among pediatric patients. Taste-masking techniques, including the use of flavoring agents, coating technologies, and complexation, have been employed to enhance the acceptability of oral medications [3]. Implementing these strategies in pediatric dentistry ensures effective treatment of infections and pain management without compromising patient compliance.

Role of phytoconstituents and natural aids

The therapeutic potential of phytoconstituents in dentistry is garnering increasing attention. Natural compounds, such as those derived from Terminalia arjuna, exhibit anti inflammatory and antimicrobial properties, making them suitable for managing oral infections and promoting wound healing [4]. Advanced extraction and identification techniques facilitate the incorporation of these bioactive compounds into dental therapeutics [5]. Moreover, the application of Phyto-nanomedicine offers a synergistic approach, combining the benefits of natural compounds with nanotechnology to enhance bioavailability and targeted delivery [6]. Such innovations hold promise in treating conditions like oral mucositis and periodontal diseases [7].

Nanotechnology and lipid carriers in oral drug delivery

Nanotechnology has revolutionized drug delivery systems, enabling targeted therapy with improved efficacy and reduced side effects. Solid Lipid Microparticles (SLMs) and nanogels have been developed for the delivery of antiviral agents like acyclovir, offering controlled release and enhanced penetration into oral tissues [8]. Similarly, semi-herbal nanogels combining clindamycin phosphate and Aloe vera have demonstrated potential in treating oral infections with reduced cytotoxicity [9]. These nanocarriers facilitate the localized delivery of therapeutics, minimizing systemic exposure and optimizing treatment outcomes in various dental conditions [10,11].

Artificial intelligence in dental diagnostics and formulation

AI is transforming dental diagnostics and treatment planning by enabling data-driven decision-making and personalized care. Machine learning algorithms can analyze complex datasets to predict disease progression, optimize treatment protocols, and enhance diagnostic accuracy [12]. In pharmaceutical formulation, AI assists in designing drug delivery systems tailored to individual patient needs, considering factors like genetic makeup, disease state and response to therapy [13]. The integration of AI into dental practice streamlines workflows, improves patient outcomes, and fosters innovation in treatment modalities [14].

Personalized medicine and 3D printing in dental applications

Personalized medicine emphasizes tailoring treatments to individual patient characteristics. The advent of 3D printing technology has facilitated the development of customized dental appliances and drug delivery systems. For instance, 3D-printed pregabalin tablets designed using Quality by Design (QbD) approaches offer personalized dosing for neuropathic pain management [15]. Such innovations enable the fabrication of patient-specific dental devices, enhancing comfort, efficacy and adherence to treatment regimens [16].

Dental relevance of systemic disease management

Oral health is intricately linked to systemic conditions, necessitating an integrated approach to patient care. Monoclonal Antibodies (mAbs) have emerged as therapeutic agents in managing autoimmune diseases like type 1 diabetes, which can have oral manifestations such as xerostomia and increased susceptibility to infections [17,18]. Additionally, the role of dietary interventions and natural aids in managing systemic conditions like Nonalcoholic Fatty Liver Disease (NAFLD) underscores the importance of holistic patient management, considering the interplay between systemic health and oral well-being [19].

Pain management and oncology care in dentistry

Effective pain management is paramount in dental care, particularly for oncology patients undergoing treatments that may cause oral complications. Understanding the knowledge and attitudes of healthcare providers, including oncology nurses, towards cancer pain management is crucial in developing comprehensive care strategies [20]. Implementing multidisciplinary approaches that encompass pharmacological and non-pharmacological interventions ensures optimal pain control and enhances the quality of life for patients with oral and systemic malignancies.

The convergence of pharmaceutical sciences and dentistry heralds a new era of innovation and patient-centered care. Advancements in drug delivery systems, nanotechnology, AI and personalized medicine are reshaping dental practices, offering improved therapeutic outcomes and enhanced patient experiences. Continued interdisciplinary collaboration and research are essential in translating these innovations into clinical applications, ultimately advancing the field of dentistry.

1. Agarwal G, Agarwal S, Goyal S (2018) Formulation & evaluation of sustained release matrix tablet of repaglinide. Open Acc Biostat Bioinform 1(2): 1-9.
2. Agarwal G, Kumar P, Agarwal S, VSN MD, AN N (2018) Formulation development and evaluation of delayed-release tablets of montelukast sodium. Asian Journal of Pharmaceutical and Health Sciences 8(3): 1960-1967.
3. Thakker P, Shah J, Mehta T, Agarwal G (2020) Taste masking of pharmaceutical formulations: review on technologies, recent trends and patents. Int J Life Sci Pharma Res 10(3): 88-96.
4. Saudagar WS, Sidram GP, Baburo GS, Agarwal G, Agarwal S, et al. (2021) Development and characterization of terminalia arjuna phospholipid complex and tablet formulation by Qbd Approach. Int J Life Sci Pharma Res 11(3).
5. Singh PA, Tushir S, Hazra S, Purewal SS, Agarwal G (2025) Novel approaches for the extraction and identification of phytoconstituents from herbs and spices. The Natural Products Journal 14(4): E060624230784.
6. Aggarwal D, Kamal CM, Agarwal G, Kumar A, Sharma D (2023) Understanding of Phyto-nanomedicine for the management of inflammation and wound healing: An outlook. Int J Pharm Sci Res 14(10): 4716-4723.
7. Aneja S, Mittal A, Dhiman N, Agarwal G (2023) A Review on phytoconstituents for the treatment of psoriasis. Pharmacognosy Reviews 17(34): 287-295.
8. Nagappa AN, Agarwal G, Chikkamath V, Agarwal S, Rani R, et al. (2016) Formulation and evaluation of acyclovir sodium solid lipid microparticles. Am J Adv Drug Deliv 4: 78-84.
9. Agarwal S, Karar PK, Agarwal G (2017) Semi-herbal nanogel of clindamycin phosphate and aloe vera: Formulation and evaluation. Modern Applications of Bioequivalence and Bioavailability 2(5): 1-5.
10. Devgan M, Karar PK, Agarwal G, Mohan A, Gangwar P (2016) In silico designing of drugs for the inhibition of AMF-HER2 complex in trastuzumab resistant breast cancer. Indian Journal of Biotechnology 15: 292-298.
11. Kar A, Agarwal DG, Agarwal DS (2023) A review on nanostructure drug carriers for treatment and management of neuroendocrine cancer. Int J Pharm Sci 14(1): 1-9.
12. Khurana S, Malik A, Narwal S, Agarwal G, Sangwan K (2024) Potential of artificial intelligence in healthcare sector. 2024 International Conference on Computational Intelligence and Computing Applications (ICCICA), IEEE, Samalkha, India, pp. 454-458.
13. Agrawal G, Tushir S, Arora D, Sangwan K (2024) Artificial intelligence in pharmaceutical drug delivery. 2024 International Conference on Computational Intelligence and Computing Applications (ICCICA), IEEE, Samalkha, India, pp. 406-410.
14. Syed MU, Agarwal G, Agarwal S (2023) An overview of the role of artificial intelligence and machine learning in pharmaceutical research and development. Latin American Journal of Pharmacy: A Life Science Journal 42(4): 1-8.
15. Gadgeppa BO, Tukaram MS, Baburo G, Sidram GP, Gaurav A, et al. (2021) Formulation and evaluation of 3D printed pregabalin tablets targeted for neuropathic pain by Qbd approach for personalized medicine. Int J Pharma Bio Sci 11(6): 1-3.
16. Kumar S, Agarwal G, Sangwan K (2025) A review on medicinal approaches of novel imatinib derivatives. Current topics in medicinal chemistry.
17. Agarwal G, Patel M (2024) Review on Monoclonal Antibodies (mAbs) as a therapeutic approach for type 1 diabetes. Current Diabetes Reviews 20(7): 23-28.
18. Otayf AY, Agarwal G, Al Khairat M, Khormi EA, Alnemi H, et al. (2025) Fructose, the sweet culprit behind nonalcoholic fatty liver disease and type 2 diabetes. Current Diabetes Reviews.
19. Xiong Y, Sharma HP, Goyal RK, Narwal S, Berwal A, et al. (2024) Bioflavonoid combination attenuates diabetes-induced nephropathy in rats via modulation of MMP-9/TIMP-1, TGF-β and GLUT-4-associated pathways. Heliyon 10(13): e33217.
20. Baalann KP, Joseph D, Bhandari A, Kulkarni P, Agarwal G, et al. (2024) Oncology nurses' knowledge, attitudes and factors in cancer pain: A systematic review. The Malaysian Journal of Nursing (MJN) 15(4): 196-212.